Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $2.05, $0.58 better than the analyst estimate of $1.47. Revenue for the quarter came in at $383.7 million versus the consensus estimate of $357.17 million.

GUIDANCE:

Medpace Holdings sees FY2022 EPS of $6.88-$7.00, versus the consensus of $6.15. Medpace Holdings sees FY2022 revenue of $1.44-1.46 billion, versus the consensus of $1.41 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.